Breast Cancer-Targets and Therapy is a leading journal in the field of oncology, published by DOVE MEDICAL PRESS LTD in New Zealand. Established as an Open Access journal in 2009, it offers a platform for researchers and healthcare professionals to disseminate innovative findings and therapeutic strategies related to breast cancer. With an impressive ranking in the Q2 category of oncology journals as of 2023, and placed at Rank #203/404 in the Scopus database, this journal facilitates the exchange of high-quality research aimed at improving patient outcomes and advancing clinical practices. Covering a wide array of topics from basic research to clinical trials, Breast Cancer-Targets and Therapy plays a crucial role in bridging the gap between scientific discovery and practical application. Researchers, professionals, and students alike will find the journal a valuable resource for the latest advancements and best practices in breast cancer treatment.

ONCOLOGY-NEW YORK is a prominent journal dedicated to the field of oncology, published by UBM MEDICA. Since its inception in 1987, the journal has served as a pivotal platform for disseminating groundbreaking research and advancements in cancer treatment, research, and education. With an ISSN of 0890-9091 and an E-ISSN of 2767-7389, it stands as an accessible resource for professionals, researchers, and students alike. The journal currently holds impressive rankings, categorized within Q3 in Oncology and Q4 in Cancer Research for 2023, reflecting its commitment to high-quality research output and contributions to the field. Despite its challenges in Scopus rankings, positioned at #283/404 in Medicine: Oncology and #188/230 in Biochemistry, Genetics, and Molecular Biology: Cancer Research, ONCOLOGY-NEW YORK continues to primarily focus on innovative cancer therapies and emerging clinical research. The journal's ongoing dedication to enhancing knowledge and understanding in oncology makes it a vital resource for all stakeholders invested in combating cancer.

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

CLINICS IN PLASTIC SURGERY is a premier journal dedicated to the field of plastic and reconstructive surgery, published by W B SAUNDERS CO-ELSEVIER INC. Renowned for its rigorous peer-review process and high-quality scholarly articles, this journal holds a prestigious Q1 quartile ranking in the Surgery category, as well as ranking #99 out of 551 in Scopus' Medicine & Surgery category, placing it in the 82nd percentile among its peers. Since its inception in 1974, the journal has provided a vital platform for the dissemination of cutting-edge research, clinical practices, and advancements in plastic surgery, catering to the interests of researchers, healthcare professionals, and students alike. Although it does not offer open access options, its content remains invaluable to those seeking to enhance their knowledge and stay informed about the latest developments in the field. With a commitment to excellence and an expansive scope, CLINICS IN PLASTIC SURGERY continues to play a crucial role in the education and advancement of surgical practitioners around the globe.

Current Breast Cancer Reports is a vital academic journal published by Springer that focuses on the latest research and advancements in the field of breast cancer. With its ISSN 1943-4588 and E-ISSN 1943-4596, this journal serves as an essential resource for oncologists, researchers, and healthcare professionals dedicated to improving diagnosis and treatment strategies for breast cancer. Spanning from 2009 to 2024, it provides a platform for high-quality, peer-reviewed articles that encompass a range of topics, including molecular biology, clinical trials, and innovative therapeutic approaches. Although it is currently classified in the Q3 category in Oncology and is positioned in the 29th percentile, the journal remains committed to elevating its academic impact and contributing meaningfully to the ongoing fight against breast cancer. As it seeks to disseminate critical findings and foster collaboration within the scientific community, Current Breast Cancer Reports is poised to be an indispensable tool for anyone keen on advancing the field.

Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.

Journal of Breast Imaging is an esteemed peer-reviewed journal dedicated to advancing the field of breast imaging, published by Oxford University Press. Since its inception in 2019, the journal has been instrumental in disseminating innovative research and clinical practices, contributing vital knowledge to the domains of Radiology, Nuclear Medicine, and Ultrasound Technology. Notably, it holds a respectable impact factor and is categorized in the Q2 quartile for both applicable categories, asserting its position as a significant resource within the scholarly community. With a commendable ranking of #153/333 in Radiology, and #31/63 in Radiological and Ultrasound Technology, the journal consistently showcases groundbreaking studies that influence best practices and set a benchmark for practitioners and researchers alike. Although it currently does not offer open access, the journal prioritizes high-quality research that is pivotal for understanding and enhancing breast imaging methodologies at a global level. By exploring topics that range from the latest imaging techniques to innovative diagnostic technologies, the Journal of Breast Imaging serves as a cornerstone for professionals seeking to enhance their knowledge and expertise in this vital area of health care.

PATHOLOGICA is a leading academic journal dedicated to the field of pathology and forensic medicine, published by PACINI EDITORE. With a rich history dating back to its inception in 1945, the journal has consistently contributed to the advancement of knowledge in these vital areas of medical research and practice. Currently ranked in the Q1 quartile for Pathology and Forensic Medicine and holding an impressive position as #42 out of 208 in the Scopus rankings, it reflects a significant impact within the academic community, boasting an 80th percentile ranking. The journal is committed to publishing high-quality, peer-reviewed articles that explore innovative research findings and clinical advancements, making it an essential resource for researchers, clinicians, and students alike. Though it does not offer open access, PATHOLOGICA continues to foster scholarly communication by disseminating cutting-edge research findings, thus playing a pivotal role in enhancing pathology education and practice worldwide.

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.

npj Breast Cancer, published by NATURE PORTFOLIO, stands at the forefront of breast cancer research as an esteemed open access journal since 2015. With its impressive trajectory, the journal has garnered a notable impact within the academic community, reflecting a Q1 ranking in prestigious categories such as Oncology, Pharmacology, and Radiology for 2023. Based in the United Kingdom and indexed under E-ISSN 2374-4677, npj Breast Cancer aims to disseminate cutting-edge research that fosters innovation in prevention, diagnosis, and treatment of breast cancer, thereby addressing one of the most pressing health issues of our time. Its placement within Scopus rankings, including a remarkable 19th position in Pharmacology and a percentile ranking in the 90th range for Radiology and Oncology, highlights its significance as a key resource for researchers, healthcare professionals, and policy-makers dedicated to advancing cancer care. Emphasizing accessibility and high-quality content, npj Breast Cancer provides an influential platform for interdisciplinary collaboration and discovery in the ongoing battle against breast cancer.